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Abstract
Background: Little is known about why parents agree to take part in randomized controlled trials for adolescent
mental health. This study aimed to investigate parents’ perspectives on participating in a trial for psychological
treatment of depression. The study explored parents’ motivations, understanding of the trial and perspectives on
the acceptability of the trial.
Methods: Sixty-five parents took part in this qualitative study. Their adolescent children had been randomly allocated
to one of three active psychological treatments for depression as part of the IMPACT trial and were interviewed about
their experiences of participating in the study. Semi-structured interviews were analysed using framework analysis.
Results: For seven of the sixty-five parents, their experience of taking part in the trial was not covered in their interview
so they were excluded from the analysis. The analysis was therefore based on the data from the parents of 58
adolescents taking part in the trial. The most commonly cited motivation for taking part in the study reported by
parents was a desire to help others going through similar difficulties. Parents generally reported finding trial
participation acceptable, although there were aspects that some reported finding less acceptable, including
randomization and the burden of research assessments. Others spoke positively about the experience of trial
participation and found it enjoyable or even therapeutic. Importantly, some did not appear to have a good
understanding of the trial design, including randomization and treatment allocation.
Conclusions: This study indicates that trial participation can be a positive experience for parents, yet it raises concerns
about how trialists can ensure that consent is fully informed, given that some parents appeared to have a poor
understanding of the trial. Future studies should seek to explore how communication with trial participants can be
improved, to ensure that trial participation is fully informed. Patient and public involvement will be crucial in ensuring
this communication is accessible to stakeholders.
Trial registration: ISRCTN registry ISRCTN83033550. Registered on 15 October 2009
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Background
Randomized controlled trials (RCTs) are considered
the ‘gold standard’ when it comes to evaluating the
effectiveness of treatments. Such studies rely upon
participation from service users, and in recent years,
there has been growing emphasis on the inclusion of
service users both in the design of such studies [1],
and in order to better understand the barriers and fa-
cilitators to study participation [2, 3]. Many clinical
trials now include a qualitative component as re-
searchers have come to increasingly appreciate what
qualitative methods can offer RCTs [4–6]. Qualitative
research within trials has been used in a range of
ways, including to explore the intervention being
studied, the design and conduct of the trial, the out-
comes and processes measured in the trial, the out-
comes of the trial, and the health problems under
study [5]. In the context of treatment for child and
adolescent conditions, it is important to include the
perspectives of both young people themselves and
their caregivers—who may have different agendas,
perspectives and ideas about what is and is not ac-
ceptable in the care of the child. The inclusion of
parents in such studies is necessary as parents will
often have a key role in psychological therapies for
their children and in some cases may be actively in-
volved in the sessions themselves [7] or maybe of-
fered individual sessions alongside their child’s
treatment [8].
In the context of treatment for mental health disor-
ders in children and adolescents, there is a paucity of
studies exploring their experiences of trial participa-
tion, including why young people decide to participate
in clinical trials, and how well they understand the
research process. In response to this, a previous study
sought to explore the experience of young people par-
ticipating in the Improving Mood with Psychoanalytic
and Cognitive Therapies (IMPACT) trial, an RCT ex-
ploring the effectiveness of psychological therapies in
the treatment of depression in young people, aged
11–17 [9, 10]. IMPACT-My Experience (IMPACT-
ME) was a sibling study to IMPACT in which a sub-
sample of the young people and parents taking part
in the trial were interviewed about their experiences
of being involved in the IMPACT trial [11]. Drawing
on data from the IMPACT-ME study, a previous pub-
lication reported the adolescents’ experiences of tak-
ing part in the IMPACT trial [12]. Results showed
that young people mostly spoke positively about par-
ticipating in the trial and their interactions with the
research assistants (who carried out six face-to-face
outcome assessments with participants over an 18-
month period), despite the lengthy assessments that
the trial involved [12]. They spoke about motivations
for taking part in the trial, including helping others
as well as hoping it would have benefits for them-
selves, such as receiving superior treatment. However,
concerns about the extent to which consent was truly
informed were identified, as some young people
seemed to have a limited understanding of the
randomization process or the different treatment in-
terventions [12]. Overall, trial participation was ac-
ceptable to these young people, but the previous
analysis did not consider the experience of parents.
Parents’ perspectives on trial participation have been
researched in trials of physical health problems. In such
studies, considerations about whether to take part in-
cluded safety and the practicalities around taking part
[13]. Concerns about trial participation from parents in-
cluded fear of losing control over their child’s treatment,
while other parents were described as having a ‘nothing
to lose’ attitude (p. 384, [14]). The extent to which these
concerns and motivations for parents consenting for
their child to take part in a clinical trial extend to the
field of child mental health is unknown.
The present study seeks to complement the previously
published study which explored adolescents’ experience
of taking part in a trial for depression [12], by exploring
the perspectives of the parents from the same sample as
the previous study. Parents provide an important per-
spective as they will usually be the ones to decide
whether to seek treatment for children under the age of
16, will be required to provide consent for their child to
participate in an RCT and in many cases will also be in-
volved in the treatment itself. Adolescents and their par-
ents may well differ in terms of their understanding of a
trial, their reasons for agreeing to participate and their
perceptions of the acceptability of the trial. Yet, no stud-
ies have been reported which explore the parents’ expe-
riences of taking part in an RCT in the field of child and
adolescent mental health. This study seeks to address
this gap in the literature—an important area for psycho-
therapy research, to ensure that studies are conducted in
an acceptable and ethical manner and to help improve
the design of future trials of psychological interventions
involving young people and their parents.
Aims
The aims of this study were (1) to explore parents’ moti-
vations for participating in an RCT for adolescent de-
pression; (2) to explore the understanding that parents
had regarding a number of aspects of participation in
the RCT, such as treatment options, randomization, dif-
ferences between research and therapy, study design and
understanding of the study’s objectives; and (3) to ex-
plore whether or not parents found participation to be
acceptable and what affected this.
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Methods
Setting for the study
This study involved secondary data analysis of interviews
carried out as part of a larger longitudinal, qualitative
study examining the experiences of a group of young
people, their parents and therapists who were taking part
in a randomized clinical trial investigating the treatment
of adolescent depression.
Trial design
The IMPACT study was a large, multi-centre RCT con-
ducted across three regions in the UK (North London,
East Anglia and the North West), to investigate the ef-
fectiveness of three therapeutic approaches for adoles-
cent depression [9, 10]. Participants were recruited from
Child and Adolescent Mental Health Services (CAMHS),
identified as potentially suitable by a clinician at the site.
The inclusion criteria for the trial were that the adoles-
cent was aged 11–17 years old and with a diagnosis of
major depressive disorder according to DSM-IV criteria
[16]. The exclusion criteria have been previously re-
ported elsewhere [10]. Participants identified as eligible
after a screening assessment were randomized to one of
the three interventions, which were as follows:
i Cognitive behavioural therapy (CBT). Focused on
identifying distorted cognitions and using explicit,
shared goals, with an intended duration of up to
20 sessions delivered over 28 weeks [7].
j Short-term psychodynamic psychotherapy (STPP).
Focused on giving meaning to the varieties of the
young person’s emotional experiences and
addressing difficulties in the context of the
developmental tasks of the adolescent years,
intended to be delivered over 28 weekly sessions [8].
k Brief Psychosocial Intervention (BPI). Focused on
sleep hygiene, exercise and monitoring risk, with
an intended duration of up to 12 sessions
delivered over 20 weeks [17].
In total, 557 adolescents were screened for eligibility,
and of those 465 adolescents met all the criteria and were
recruited into the IMPACT trial. Of those recruited, they
were randomized in relatively equal numbers to the three
treatment arms (CBT n = 154, STPP n = 156, BPI n = 155).
Adolescents received £15 as a thank you for each research
meeting that they took part in.
Qualitative study
Linked to the IMPACT trial was its qualitative sibling
study, IMPACT-My Experience (IMPACT-ME), which
took place in the North London trial centre [11]. The
IMPACT-ME study sought to explore the experiences of
those taking part in the IMPACT trial in North London
(n = 127). Due to resource issues, those participants in
the other trial regions were not invited to take part in
the IMPACT-ME study.
IMPACT-ME was a longitudinal study in which face-
to-face interviews were conducted separately with the
young people and their parents taking part in the IMPA
CT trial—before (baseline) and after therapy (36 weeks)
and at 1-year follow-up (86 weeks). The baseline inter-
views were not included in the present study, as they did
not explore the experience of the research as this was
prior to the participant being randomized into the study.
The present study draws on interviews conducted with
parents at the post-treatment time points—i.e. 36 and
86 weeks, between October 2011 and January 2014. Of
the 127 young people who took part in the IMPACT
trial, where possible, their parents were invited to take
part in the IMPACT-ME study. This was not possible
for 43 young people who were aged 16 or 17 years old,
who were taking part in their trial without the involve-
ment of their parents. Of the remaining 84 where the
parent had given consent to take part in the IMPACT
trial, 19 parents did not take part in the IMPACT-ME
study as they were unavailable or declined to be inter-
viewed. In total, interviews were therefore collected with
the parents of 65 young people taking part in the IMPA
CT trial.
In the IMPACT-ME study, separate versions of the
interview schedules were used for adolescents and par-
ents. These versions covered similar topics, while the
parent version covered aspects of the experience specific
to the experience of being a parent of an adolescent in
the trial, e.g. concerning their own experiences as par-
ents, both in relation to treatment and study participa-
tion. In a previous study, the experience of taking part in
the trial from the perspective of adolescents was re-
ported [12]. The present study is a complementary study
reporting on the parents of those same cases.
Researcher characteristics and reflexivity
Interviews were carried out by six members of the IMPA
CT-ME research team, who were research assistants or
PhD students, with specific training in in-depth inter-
viewing. The majority of the parent interviews were car-
ried out by a PhD student who was exploring the
experiences of parenting an adolescent with depression.
Data analysis for the present study was carried out after
the report on adolescents’ experiences of taking part in
the IMPACT trial had been published, and thus, the re-
searchers did know the results of the earlier study when
analysing and writing up the current study. The research
team were aware of the potential bias this may have im-
posed on the data analysis, due to the potential risk of
looking for ideas or themes that had been found in the
earlier study. To counter this, we ensured that all
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interpretations were grounded in the data, by reaching
consensus within the team on each of the themes in the
analysis. Having conducted the analysis, we then expli-
citly went back to the adolescent paper and compared
the findings, to see how their accounts were similar and
different and report on these comparisons in the discus-
sion of this paper (see the ‘Discussion’ section).
Sample and data collection
The sample consisted of interviews with parents of 65
adolescents, who were distributed fairly evenly amongst
the three treatment arms (BPI = 23, CBT = 20, STPP =
22); however, as the primary participants of the main
trial were the adolescents, little demographic data was
collected concerning this group of parents. When both
parents were available to be interviewed, they were both
invited to take part in the study and were interviewed
together. Of the 65 families, the mother and father both
took part in five cases, only the mother for 57 cases and
only the father for three cases. The children of these
parents had an average age of 14.75 years (range 11.38 to
17.84 years), and 65% were female.
Parents took part in semi-structured interviews using
the Experience of Therapy Interview [15] at the end of
therapy (36 weeks) and 1-year follow-up (86 weeks). The
interview schedule (see Additional file 1) covered two
key areas: the parents’ perspective on their child’s ther-
apy and their perspective on taking part in the trial. The
former has been reported elsewhere [18, 19], and the
present study focuses on the analysis of data in relation
to parents’ experiences of taking part in the research.
The interview schedule provided open questions and a
loose agenda for the key areas to be explored in the in-
terviews, while also providing flexibility for the interview
to focus on the area’s most pertinent to participants. Re-
search assistants conducted audio-recorded semi-
structured interviews, which had an average duration of
64 min (SD = 13.52). In order to gain as comprehensive a
view as possible of their experiences of the trial, this
study draws on data from both the 36-week and 86-
week interviews, which were regarded as one account
during analyses. The interviews were transcribed verba-
tim, anonymized and entered into qualitative analysis
software, NVivo Version 12.0 [20].
Data analysis
Data were analysed using framework analysis [21, 22].
Framework analysis is a data management and analysis ap-
proach which is integrated into the NVivo qualitative data
analysis software and is suitable for studies with specific
research questions, a pre-designed sample and a priori is-
sues to investigate [21, 23]. The main a priori defined
topics that we looked at were motivation to participate,
acceptability of trial participation and understanding of
different aspects of participation. Acceptability of trial par-
ticipation was a focus of the interview schedule and as
such was defined at an early stage in the research as a key
area of interest for the research team. Other topics be-
came of interest during the data collection phase of the re-
search, where issues around motivation and variation in
the way in which parents understood the research came
up during the interviews—and as such, were defined prior
to formal data analysis as key areas for further
exploration.
In relation to these three a priori concerns, subcat-
egories emerged from the content of the interviews. The
second and third authors developed an initial coding
framework in line with the aforementioned three main
categories. One coder was a postgraduate researcher,
and the second was a post-doctoral researcher; one of
them was not clinically trained, and the other was a
trained systemic therapist. To develop the framework,
they coded the first 24 interviews together with the aim
to develop a comprehensive, consistent and clear coding
framework. They worked through each interview, line by
line, assigning codes to each unit of meaning that told
us something about one of the three a priori areas of
interest for this study. Following this, they coded four in-
terviews with this framework separately which were then
compared to check reliability. To ensure that the coding
framework was sufficiently comprehensive and reliable,
the last author coded one interview using the framework
and the feedback was used to further clarify the categor-
ies. The coding framework was finalized after coding
these 29 interviews. The framework was then used to
index and summarize the remaining interviews based on
the coding framework.
Having coded all of the interviews into the NVivo soft-
ware, the team then began the interpretation of the data
coded to each of the three key issues: motivation, ac-
ceptability and understanding of the research—to make
meaning from the range of experiences within each of
these domains, seeking to identify similarities and differ-
ences between participants’ experiences. In addition,
each case was coded on a global level in terms of the
main motivation for participation, general acceptability
of participation and the overall understanding/lack of
understanding of participating in the RCT.
Ethical considerations
The IMPACT and IMPACT-ME study protocols were
approved by the Cambridgeshire 2 Research Ethics
Committee, Addenbrooke’s Hospital Cambridge, UK
(REC Ref: 09/H0308/137). Fully informed written con-
sent was sought from both adolescents and their parents.
Participants were identified having sought help at
CAMHS and depression being considered as the main
presenting problem for the adolescent. The assessing
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clinician would briefly describe the study to them and
ask if they were happy to be contacted by a researcher
from the trial team. If they gave verbal consent to be
contacted by the trial team, the researcher would phone
the parent and/or adolescent and explain the study in
detail to them and post out the participant information
sheet. There were separate, age-appropriate information
sheets for younger (11–15) and older (16–17) adoles-
cents, as well as parents. Following this, if the young per-
son and (for those under 16) the parent both verbally
agreed to take part, a screening assessment to assess eli-
gibility for the trial would be scheduled, and at this
point, fully informed written consent was sought. The
researcher taking consent would go through the full de-
tails of the trial, including explaining the three treatment
arms, using a pre-agreed description of each treatment,
the randomization process and what involvement in the
research would involve. Consent was re-affirmed verbally
with participants at each research interview.
Results
Findings are presented in three sections, following the
three research aims of the study. In order to protect the
confidentiality, identifiable details are excluded or dis-
guised and participants have been assigned pseudonyms.
For seven of the 65 parents, the interview focused en-
tirely on the parents’ views of their child’s therapy, and
the interviews were ended before the interviewer could
ask about the parents’ experiences of taking part in the
research itself. For the remaining 58 parents, not all
spoke about all aspects of experience covered in the
framework, and so the number of parents reported in
each section of the results varies.
Although the parents in this study were in one of three
treatment arms, the focus of this study is on their ex-
perience of the RCT rather than of treatment itself. Dur-
ing the analysis, we were conscious to look for potential
treatment arm differences in participants’ experiences,
but the experience of parents did not appear to differ by
treatment arm, so in what follows, results are reported
without reference to specific treatment arms.
Motivation for taking part in the trial
Conditional altruism
The most common motivation for participating in the
study was to help others, with 17 of the 58 parents
(29%) reporting this as their motivation. They reported
wanting to help other people, contribute to the study
and potentially help with the development of services
and provision for young people with depression:
If any good can come out of this and if some more
support can be put through, if the government get
involved with this, so they can have more support
within schools to try and lift the spirits of some of
these kids then that’s what I’m happy with. (Ms
Austin, mother of 16-year-old girl)
Six parents spoke about a feeling that participation in
the study was something that ‘needs to be done’. This
reflected their understanding of the need for research to
help identify the most effective treatments for adolescent
depression, and thus were accepting of being involved.
Alongside this, parents described the motivation to help
others, while also hoping for benefits for their own child.
Potential benefits to trial participation
Another common motivation for participating in the trial
was to get help for their child and themselves. Fourteen
parents spoke about their participation in the study in rela-
tion to getting treatment. The predominant theme seemed
to be a relief at the trial offering some form of support:
I was kind of sort of at the end of my tether and I
was just so pleased to be plugged into something,
that’s kind of it. I keep, you know, I was very happy
she got the CBT but if she got something else it
wouldn’t have bothered me too much because I was
just so pleased to get some kind of help. (Ms Too-
mer, mother of 16-year-old girl)
Ten parents reported their motivation was to get faster
treatment than they would otherwise have been offered,
while one parent reported that they felt they would be
offered better treatment though the trial because ‘they’re
[the therapists] gonna have to do everything by the
books’ (Ms Heron, mother of a 16-year-old girl).
Parents also spoke about what they thought their
child’s motivation for taking part in the trial was. Nine-
teen parents thought that money was the main motiv-
ation for their child’s participation (as they received a
‘thank you’ payment for participating in the research
meetings). Seven parents reflected that being part of the
study gave their child a sense of not being alone, and
made the young people feel special:
For her she’s excited ‘cause she knows that she’s go-
ing to be part of history. (Ms Featherstone, mother
of 16-year-old girl)
Thus, there was a range of reported motivations for par-
ticipation including altruism as well as potential per-
ceived benefits for the parent and/or child.
Understanding of the trial
General understanding of the trial
Of the parents who spoke about their understanding of
the trial, there was a similar proportion of parents who
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seemed to have a reasonable overall understanding of
the study (17/36 parents; 47%) to those who seemed to
have a general lack of understanding of the study (19/36
parents; 53%).
While eight parents demonstrated some understanding
of the difference between research and therapy, seven par-
ents seemed to be confused about the difference and more
specifically the roles of researchers and therapist. For in-
stance, one parent asked the research assistant ‘are you a
doctor… maybe you are a psychiatrist or come from men-
tal health?’ (Ms Sauter, mother of 14-year-old girl).
Of the 11 parents who referred to the objectives of the
study, eight (73%) had a good understanding of the aims
and objectives of the study, with all referring to the idea
that the study was aiming to help professionals learn
more about which treatments are helpful for depression:
So, my understanding is that the IMPACT study,
you’ve basically, you’ve kind of followed people, or
young people who have been in some kind of talk-
ing therapy, over the course of however long. So
that is just gonna help understanding of which ther-
apies work best for which types of individuals, right?
(Ms James, mother of 17-year-old boy)
On the other hand, three parents seemed to be unable
to remember or were confused about the objective of
the study.
I think for me it was a research on how the session
works for adults or… am I right? (Ms Bland, mother
of 15-year-old boy)
With regard to consent, three parents gave the impres-
sion that they understood the process of informed con-
sent, stating that they felt they had the right to stop
participating or withdraw from the study:
You know, they said, ‘would you think of being involved
in this?’ And I was kind of in two minds. I was thinking,
if throughout, you know, as part of the randomization
process he got the psychotherapy, I did kind of think
that I might consider pulling out if I didn’t feel that was
the best therapy necessarily for [my son] at the time.
(Ms James, mother of 17-year-old boy)
Understanding of the treatment allocation process
Of the 24 parents who spoke about treatment allocation,
14 (58%) parents seemed to demonstrate a lack of un-
derstanding of the randomization process. This varied
from stating that they did not know about
randomization or could not remember it to feeling that
it would have been better to have a choice between
treatment arms, to those who stated that they believed
the professional would choose the ‘right’ treatment for
their child.
I thought I’ll leave it to the team, you know, well,
I’ll leave it to when they’ve done the assessment. I
trusted the assessment. I trusted it, that it would be
the right one for her, you know, that it would be the
right team for her. (Ms Monte, mother of 14-year-
old girl)
In comparison, ten parents (42%) seemed to have a good
understanding of randomization. These parents under-
stood the necessity for randomization of treatment as
part of a research study, the fact that there were three
different treatments that their children could be ran-
domized to and that all treatment options were poten-
tially helpful.
I suppose again it’s the research, isn’t it? So, you
know it’s kind of like we are guinea pigs in some
ways and so it’s kind of like to me…you know you
have to do it in a certain way you know and so
there’s maybe not scope for those kind of more
one-to-one things you know, more individual ten-
sion, erm really. I just think it’s the research that
needs to follow certain ways of doing things and
making it kind of a fair system. (Ms Heron, mother
of 16-year-old girl)
Of the 17 parents that spoke about the treatment op-
tions, nine (53%) showed an understanding of the differ-
ent treatment options. They spoke about the different
treatments, in some cases remembering the names of
them, but giving the impression that they had a sense of
the differences between them.
I was actually quite pleased when I heard that he
got the CBT... just because again I’d done some
quick research into and because I think obviously
we... were at a really desperate stage. It seemed to
me that CBT – from what I’d heard and from
friends that have done CBT - I had the impression
that that was the one that got quite quick results if
not necessarily long-lasting results. (Ms James,
mother of 17-year-old boy)
In contrast, eight parents did not seem to have such a
clear understanding of the differences between the treat-
ment options, stating that they could not remember what
they were and, in some cases, explicitly saying that they
did not have a good understanding of the differences:
It was pot luck and since we didn’t really have a
good understanding of the different kinds of therapy
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so we sort of thought, well... you know, I came back
and spoke to [my daughter’s father] and we just sort
of thought, well, because we don’t... she actually
couldn’t care less at that point who she saw. (Ms
Porter, mother of 17-year-old girl)
These findings indicate a substantial variation between
parents with respect to how well (or not) they under-
stood the research study.
Acceptability
Of the 57 parents who referred to the acceptability of
participating in the trial, 50 of them (88%) found partici-
pation to be generally acceptable, with seven (13%) find-
ing participation to be generally unacceptable. Parents
discussed the acceptability of the trial across a number
of domains, including the process of randomization to a
treatment arm, the research meetings and some specific
issues around confidentiality, feeling pressured into tak-
ing part and financial incentives for participating. Each
of these will be discussed in turn.
Randomization
Of the 23 parents who referred to the randomization
process, 13 (57%) gave the impression of finding it to be
acceptable. They reported that they did not mind that
treatment was randomized as they were relieved to be
getting help. Other parents stated that they trusted the
professionals so felt able to leave treatment allocation in
their hands, while one even found it preferable that the
treatment allocation had been random:
I don’t think it made any difference to her at all, no,
um I think that it’s such a new world for her, it
didn’t make any difference. And even if someone
had said to me which would you like, I wouldn’t
have known what to choose. I really wouldn’t have
known at all so in a way... probably the best thing.
(Ms Adams, mother of 13-year-old girl)
However, eleven parents gave the impression of finding
the randomization process unacceptable. Amongst the
main reasons for this seemed to be an idea that a ran-
domly selected therapy may not be what was best or
most suited to their child, that the young people and
parents should have the right to choose, and subsequent
anxiety about whether they would be allocated to the
right treatment or to a treatment that they deemed to be
inadequate or unfavourable:
I would’ve liked it to be a little bit more tailored,
like or at least be able to have the choice of the
three. At the time, I remember thinking, I remem-
ber thinking, well, I’d prefer her to have, erm, cos I
had the leaflet with the… I dunno where that is
now! But there were three different choices, options
and I don’t think she got the one that I thought
sounded most helpful. (Ms Woods, mother of 13-
year-old girl)
As demonstrated in the excerpt above, some parents
were unhappy with the principle of randomization and
specifically the lack of choice over the treatment their
child received. Four parents spoke specifically about how
they felt their child had been allocated to the wrong
therapy and that the randomization process meant that
the needs of their child would not be met appropriately.
Research assessments
Another key aspect described by parents was with re-
spect to how acceptable (or not) the research assess-
ments were. Twenty-three parents reported finding the
opportunity for themselves and the young people to talk
about their difficult experiences with a member of the
research team a positive, helpful and therapeutic aspect
of the study. For example, one parent described how
completing the outcome measures for the trial had pro-
vided an opportunity for their child to express them-
selves and that this had helped them.
I do feel though that you know with doing the
IMPACT it has helped him a lot. Erm, because I
think like with all the questionnaires, that he’s done,
it’s made him sort of understand a bit more about
his own feelings. Because it is hard, you know, for
children to express themselves. (Ms Baker, mother
of 12-year-old boy)
Seven parents seemed to find the demands of participa-
tion manageable, or even enjoyable. The predominant
feeling was that participating was not too demanding or
‘too onerous’ with meetings only ‘once every couple of
months’.
It’s an hour out of my day and for you it’s the end
of two years’ hard work… so for me, I just, yeah,
didn’t think twice. I came because… you needed me
to come. A lot of people won’t bother, and they
won’t come and then you will have lost them and
then, for me it’s an hour out of my morning so
that’s fine, that’s cool. (Ms Thomas, mother of 12-
year-old boy)
However, 21 parents reported finding the study burden-
some. These participants spoke of feeling that participa-
tion in the study was time-consuming and intensive.
The length of the meetings with the research assistants,
particularly the initial, baseline assessment meeting
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(which typically lasted up to three hours), also seemed
to be unacceptable to them, with phrases such as ‘too
much all at once’ and ‘awful’ being used to describe the
experience. Some parents spoke of the difficulty of going
back over difficult experiences and the pain of talking
about their child’s distress:
Yeah, and it is hard going back over it again, you
know, it is, cause they were really upsetting times
but I know that at the first interview, the first IMPA
CT interview I did, I was, you know, I did have a bit
of a cry, you know, and I know and [my daughter]
was like, had a box of tissues and so on. (Ms Cree-
don, mother of 17-year-old girl)
Parents also spoke of some specific criticisms of the
study relating to the volume of questions that they had
to answer, with some questionnaires seeming repetitive,
irrelevant or tedious; limiting answers to time scales that
felt too short or too broad; and the scoring scales seem-
ing irrelevant, e.g. ‘0–10’:
It was kind of, you know, on a scale of (a) you know
very poor going right through up to excellent or
whatever erm... ‘how’s this been, how’s that been,
how’s the other been?’ And yeah, that’s, that’s quite
a difficult one to answer and also kind of compli-
cated but sometimes you’ll read the situation and
think I’m not sure this applies or does it apply, or I
don’t know if it applies but I’m not sure how easy it
is to get around that. (Ms James, mother of 17-year-
old boy)
Other parents described finding the questionnaires inter-
esting and some find that as the study progressed, the
questionnaires helped with their understanding and
awareness of their child’s depression:
Some of the questionnaires that I filled in made me
understand a bit more about psychological issues.
So, for example, people who suffer from depression,
or any kind of low mood, I didn’t know that they al-
ways feel tired all the time, you know, and my
daughter feels tired all the time. So, you know there
are things like that, even though they didn’t say it in
the questionnaire, I could read between the lines,
where they were going with this. So, it gave me an
insight to go and look up certain things, to work
out why she was like she was… So, in some respects
it’s helped me to tailor, the way that I look and treat
her. (Mr Watterson, father of 14-year-old girl)
A positive aspect often spoken about by parents was
with respect to the research assistants they had met with
during their participation in the study. Thirty-one par-
ents reported that they had had positive experiences
with the research assistants, describing them as friendly,
helpful, non-judgemental, understanding and profes-
sional. Research assistants gave the option for the re-
search assessments to take place in the family home,
which parents often spoke positively about:
I love the fact you come here. I have to say it
sounds like a really small thing but actually particu-
larly if you’re traipsing left right and centre to ap-
pointments with, with your daughter you know
another appointment on top of that somewhere else
would have just probably been the final straw so for
it to at least be here it makes life an awful lot easier
so that was a good thing. (Ms Adams, mother of 13-
year-old girl)
While parents were often positive about their experi-
ences with the research assistants, one issue that was
raised was staff turnover, as the research assistants often
changed over time. Eleven of the parents reflected that
they did not mind changes in the research assistants,
while 19 parents seemed to find changes in the research
assistants less acceptable, stating that they liked having
consistency and continuity in the research assistants that
they met with. The advantage of having consistency with
research assistants from the parent’s perspective was that
it allowed for a relationship or rapport to be built up
with them and with their child.
Issues with confidentiality
A small number of parents spoke about specific aspects
of the study they did not find to be acceptable. The issue
of confidentiality was discussed by four parents, who
raised concerns about whether the research data would
be confidential. Understanding that their data would be
confidential was described as making participation ac-
ceptable for one parent. One parent expressed significant
dissatisfaction with the information their child shared
with the researcher not being shared with them as
parents:
I want to know how my son is doing... because I think
he’s doing ok and... but maybe just maybe he’s hiding
it better from me... and then, if something happens to
him, if he does kill himself, where do I go? I’ll come
to you and I will blame you for it... because when I
ask how he’s doing... you can’t give me the answer.
(Ms Kowalski, mother of 16-year-old boy)
This reflects concerns around the research procedures,
which would protect the child’s confidentiality, unless
there were specific safety concerns.
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Feeling pressured to take part
A specific issue with the trial raised by one parent was
that they felt pressured into taking part in the trial:
It didn’t feel that we had much of a choice, to be
honest. When we went along, initially I thought that
you know but it was already like, well, this is the
study, the IMPACT study and we were kind of like
encouraged to do it. It was kind of like as if to say,
well, you’re gonna get a lot more involvement in
this and you know it’s gonna be…recorded and
everything and all the plus sides of it which is good,
but it just made you think, well, you didn’t have a
choice! Well, we did have a choice but, you know,
you’re kind of like pushed into it a little bit and that
kind of thing. Erm…so you went along with it. (Ms
Heron, mother of 16-year-old girl)
The perceived feeling of lack of choice over whether to
participate in the study implied an issue of feeling pres-
surized to participate in order to access treatment for
their child, due to lack of alternatives for seeking timely
treatment. For another parent, an aspect of the study
that they described as less acceptable was the financial
incentives given to the young people for participating in
the study:
My only thing about that is my one little criticism I
have and I can understand is how they get paid...and
I know I think we might and she got £40... and she
didn’t even expect it, but she was like, she went out
and bought a load of make-up... but obviously per-
haps research has shown that is a motivating factor
with young people, but I find that a little bit hard to
take. (Ms Thomson, mother of 15-year-old girl)
This raises a specific question about the acceptability of
‘thank you’ payments for participants in research studies,
which may be an important motivating factor for trial
participation.
Discussion
This study aimed to investigate parents’ experiences of
participating in a clinical trial, in the context of a psy-
chological treatment RCT for adolescent depression: the
IMPACT trial [9, 10]. The study explored parents’ moti-
vations for participating in the trial, their understanding
of the trial and their perspectives on how acceptable
they had found participating in the trial.
With respect to parents’ motivations for taking part in
the trial, a wish to help others who might be facing simi-
lar situations was most commonly cited. Conditional al-
truism has been referred to as a primary motivating
factor for trial participation in previous studies—that is,
taking part in the hope it will help others, while also
hoping they will benefit from it themselves [24]. These
motivations are in line with the findings from a meta-
synthesis of factors affecting recruitment of adults into
depression trials [25]. These also overlap with the moti-
vations reported by adolescents themselves for taking
part in the same study [12], suggesting a shared motiv-
ation to participate in clinical trials between young
people and their parents. Some parents’ motivation for
participating in the trial was due to perceiving they
would get faster or superior help than would have been
on offer otherwise. Although all those who chose not to
participate would still have been offered help at CAMH
S, the concern about potentially long waiting lists may
have impacted on the perceived choices that parents and
young people had. This is an important reflection of
overstretched CAMHS in the UK public healthcare sys-
tem—meaning that for some of these parents, they felt
they had little choice as they felt that the research would
provide the quickest route to help for their child. Some
parents also reported that for their child, their main mo-
tivation had been the ‘thank you’ payment for participat-
ing in the research assessments—an issue that was also
mentioned by the young people who participated in the
IMPACT study [12]. The use of payments for research
participants has been controversial, with some authors
arguing that such payments can be coercive [26]. Moti-
vations for taking part in the study thus encompassed
both an altruistic component, alongside perceived bene-
fits for them or their child.
A basic ethical requirement for modern-day research
is that participants should be fully informed as to what
study participation will involve [27]. The present study
raises some concerns about the extent to which partici-
pation of parents was truly informed, given that a sub-
stantial minority of the participants in this study did not
appear to fully understand the study. While this may be
a case of parents not remembering the details of the
trial, consent was re-affirmed at each research meeting,
suggesting that for some parents, they had not fully
understood the trial information. Some parents appeared
unsure of the distinction between the research and ther-
apy and were unclear about the different interventions
on offer through the study and the treatment allocation
process. Several parents did not appear to understand
randomization, an aspect of trial participation that other
authors have identified as being difficult for participants
to understand [28, 29]. The distinction between research
and clinical care was not always clear to these parents,
linking with the literature on ‘therapeutic misconcep-
tion’, where participants believe that every aspect of the
research is intended to be for their benefit [30]. Some
parents in this study reported believing their child would
be allocated to the right treatment for them, indicating
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an expectation for individualized care for their child.
The issue of therapeutic misconception is cited as being
more exaggerated in psychological trials compared with
pharmacological trials, as such trials frequently involve
testing interventions that have clinical equipoise and
parents will often have expectations that the profes-
sionals conducting the trial are functioning with the
child’s needs as their top priority [31]. In addition, in
psychological trials, the distinction between the interven-
tion (meeting a professional and talking together about
your psychological well-being) and a research interview
(meeting a researcher and talking together about your
psychological well-being) may not be as easy to establish
as it is in trials involving medication.
Despite some issues in parents’ understanding of the
study, the majority found participation in the trial to be
acceptable. Previous studies reported that participants
frequently describe disappointment when allocated to
the control group [32, 33], especially when parents have
a preference towards one of the treatment arms [32]. In
this study, parents rarely expressed a preference for one
specific type of treatment, potentially due to the IMPA
CT trial involving three active treatment arms, which
may have made the randomization process more palat-
able than in studies where participants may be allocated
to a control or treatment as usual group. This was
prominent in several of the parents’ accounts, who spoke
about the relief of getting help, regardless of which of
the treatments their child received. This may reflect par-
ents having little preference amongst different types of
talking therapies, as it may be difficult to understand the
differences between them, especially for those without
previous experiences of psychological treatment. Never-
theless, in this study, some parents did find the
randomization process to be unacceptable, due to fears
about their child receiving a treatment that may not
have been right or best suited to their child.
The research assessments were also frequently referred
to, and parents again varied in how acceptable they
found them. While some reported that they were not de-
manding and some even found them helpful or thera-
peutic, others were more concerned about the burden
the assessments placed on them and/or their child. The
number of questionnaires and length of the assessments
were referred to, with the baseline research assessment
seeming to be the least acceptable. These assessments
were typically the longest, and there was a sense of it be-
ing too much to deal with at a very difficult time in their
lives. In the IMPACT study, a lengthy battery of ques-
tionnaires and interviews had been included in this base-
line assessment. However, after the study began, this
feedback from families led the trial team to reduce the
participant burden. Parents often spoke positively about
the research assistants who they had met with
throughout the study. The sense of having friendly and
non-judgemental research staff, who were flexible to
make the appointments convenient for the family, was
striking—and were potentially important in making the
study generally acceptable to parents. This is an issue
which has not been widely commented on in the litera-
ture to date, and may be worth considering, especially as
trials are increasingly moving to remote or online data
collection where face-to-face contact with the research
team may be reduced [34].
There were also specific concerns about the study
raised by a minority of parents. The issue of confidenti-
ality was raised, with one participant expressing con-
cerns about not being kept informed about their child’s
progress from the research assessments. We are unaware
of previous studies that have cited this finding, but is an
important consideration when working with parents of
children where there are specific concerns around risk.
This raises an issue of working with adolescents, in strik-
ing the balance between the young person’s right to con-
fidentiality and the concerns of the parent about their
child’s safety. However, this is likely to be an extension
of what may occur in treatment with young people out-
side of a research study, where parents feel they want to
know what is happening in their child’s therapy.
Recommendations for trial design
This study suggests that most parents identify clear mo-
tivations to take part in clinical trials in the field of child
and adolescent mental health and overall found the re-
search process acceptable. This study shows us that trial
participation can be a positive experience for parents.
Positive interactions with research staff and flexibility of
researchers are important considerations from the per-
spective of parents participating in clinical trials. Includ-
ing young people and parents in the recruitment of
researchers is one way that their views can be valuable,
to ensure that trial staff have the qualities deemed im-
portant from the perspectives of parents, as this was a
crucial aspect of acceptability in this study. Indeed, we
included parents and young people on interview panels
in the recruitment of staff for the IMPACT-ME study,
and this was hugely important to ensure that the team
were people who participants would feel comfortable
with during interviews, given the sensitive nature of the
project the team were responsible for.
There are however important considerations for the
design of future trials. First is the issue of how to ensure
that consent is fully informed. In this study, parents did
not always have a clear understanding of the purpose of
the clinical trial, the rationale for randomization or what
participating would involve. Parents were making a deci-
sion about whether to participate in the trial at a very
stressful point in their lives, where their primary concern
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was to access help for their child’s mental health prob-
lems. One reason for taking part was to get quicker ac-
cess to help for their child. However, even when clinical
resources may be scarce, and there is the possibility of
long waiting lists for treatment, participants should not
feel pressured into taking part in studies and they should
feel it is a choice as to whether to take part.
Future studies should seek to find better ways of
communicating with potential participants the aims,
objectives and research process—as existing informa-
tion sheet design appears insufficient for communicat-
ing such complex information. A possibility might be,
for example, to arrange a meeting with each partici-
pant young person and parent, to talk through the in-
formation sheet, to ensure that the issues have been
understood and to discuss pros and cons, rather than
just to give the sheet to the participant and give them
a chance to raise questions. Potential participants may
not know that they have not understood the study
design, or how to frame a question or concern, with-
out help from someone more familiar with the re-
search and treatment conditions. Alternatively,
researchers could seek to establish more creative ways
of communicating study information to participants.
For instance, short films or animations may be a
more engaging way to communicate key information
about the study to participants [35], compared with
the existing information sheets, which can be dense
with information and may overwhelm some partici-
pants. Patient and public involvement in developing
such resources are crucial to ensure that study mate-
rials are accessible for people with varying degrees of
literacy and from different cultures. Indeed, this ap-
proach has been found to ensure that research infor-
mation and tools are user-friendly and accessible to
participants [36]. However, issues remain about the
lack of systematic reporting about patient and public
involvement in research [37]—which limits the way in
which researchers can build cumulative knowledge
about the most effective ways of involving stake-
holders in research.
In the 10 years since the IMPACT trial was designed,
there has been an increased emphasis on public and pa-
tient involvement (PPI) in research. This study reflects
the valuable insight that parents can provide in the de-
sign and delivery of research. Patient and public involve-
ment should be included at all stages of the project,
such as reviewing trial materials as part of developing re-
search protocols and seeking ethical approval [38] and
extend into the training of researchers. For instance, par-
ents could be involved in training research staff to en-
sure they communicate effectively with participants and
understand the priorities and needs of potential research
participants.
Strengths and limitations of this study
A strength of this study is its relatively large sample
size, based on in-depth interviews with parents about
their experiences of participating in a clinical trial.
Although qualitative studies often benefit from having
smaller sample sizes, to allow detailed analysis of in-
dividual experiences, having a larger sample size
makes it possible to include a broader range of expe-
riences and is recommended in framework analysis
[21]. The study used semi-structured interviews with
parents, allowing in-depth exploration of the topics
most pertinent to participants and openness to the
unexpected. While this allows the interviews to be
participant-led, a limitation of this approach is that
participants were not systematically asked about all
elements of the study. It is therefore possible that
some important opinions on specific aspects of the
study may not have been expressed. The sample com-
prised only those who had already agreed to partici-
pate in the trial. It is unknown how representative
these findings are of those parents who declined to
participate in the trial or those who withdrew from
the study—who may have quite different perspectives
from those represented in the present study. A fur-
ther limitation of the study is that limited demo-
graphic information was obtained from parents, and
further, data on whether the parents had previously
taken part in clinical trials, which would influence
their understanding and perspectives of trial
participation.
Finally, this study emphasizes the importance of PPI in
all aspects of trial design and delivery. We note that the
IMPACT trial was designed over a decade ago, when
there was less emphasis on the inclusion of PPI, and
funding bodies did not routinely require applicants to
incorporate PPI work into their proposals. Since this
time, there has been an important shift, and we hope
that learning from this study can help others to consider
the range of ways in which PPI can benefit research de-
sign and conduct.
Conclusion
This study has helped to explicate parents’ motiva-
tions, benefits and burdens of participating in a trial.
This study shows that the IMPACT trial was gener-
ally acceptable to parents, and the aspects of the
study that parents had an issue with largely over-
lapped with those of the adolescents reported in a
previous study [12]. Nevertheless, there were indica-
tions that not all parents gave fully informed consent
to take part in the study, and there were a number of
elements of the research design which some parents
were not happy with. Together with the earlier study
looking at the experience of young people taking part
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in the same clinical trial [12], these studies provide a
wealth of information that can help to inform future
trial design, to ensure that trials for young people in
the field of child and adolescent mental health are ac-
ceptable, ethical and minimize the burden to both
young people and their parents.
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